Chimeric Therapeutics Limited

Chimeric Therapeutics Limitedverified

CHMMF

Price:

$0.001

Market Cap:

$10.93M

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The compan...[Read more]

Industry

Biotechnology

IPO Date

2022-11-30

Stock Exchange

OTC

Ticker

CHMMF

The PE Ratio as of December 2025 (TTM) for Chimeric Therapeutics Limited (CHMMF) is -0.10

According to Chimeric Therapeutics Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.10. This represents a change of -154.87% compared to the average of 0.18 of the last 4 quarters.

Chimeric Therapeutics Limited (CHMMF) Historical PE Ratio (quarterly & annually)

How has CHMMF PE Ratio performed in the past?

The mean historical PE Ratio of Chimeric Therapeutics Limited over the last ten years is -255.60. The current -0.10 PE Ratio has changed -96.09% with respect to the historical average. Over the past ten years (40 quarters), CHMMF's PE Ratio was at its highest in in the December 2023 quarter at 2.00. The PE Ratio was at its lowest in in the December 2019 quarter at -761.68.

Quarterly (TTM)
Annual

Average

-255.60

Median

-1.54

Minimum

-1523.37

Maximum

-0.52

Chimeric Therapeutics Limited (CHMMF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Chimeric Therapeutics Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 57.33%

Maximum Annual PE Ratio = -0.52

Minimum Annual Increase = -99.60%

Minimum Annual PE Ratio = -1523.37

Quarterly (TTM)
Annual
YearPE RatioChange
2025-0.52-48.12%
2024-1.0057.33%
2023-0.64-69.50%
2022-2.08-65.40%
2021-6.02-99.60%

Chimeric Therapeutics Limited (CHMMF) Average PE Ratio

How has CHMMF PE Ratio performed in the past?

The current PE Ratio of Chimeric Therapeutics Limited (CHMMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.72

5-year avg

-2.05

10-year avg

-255.60

Chimeric Therapeutics Limited (CHMMF) PE Ratio vs. Peers

How is CHMMF’s PE Ratio compared to its peers?

Chimeric Therapeutics Limited’s PE Ratio is greater than Quantum Genomics S.A. (-0.79), less than Theralink Technologies, Inc. (-0.00), less than LianBio (4.68), greater than Curative Biotechnology, Inc. (-2.45), greater than BetterLife Pharma Inc. (-4.01), greater than PharmaTher Holdings Ltd. (-4.54), greater than Tristar Wellness Solutions Inc. (-6747.12), less than NanoSphere Health Sciences Inc. (0.17), greater than Glow Lifetech Corp. (-3.57), greater than ProText Mobility, Inc. (-1526.99),

Build a custom stock screener for Chimeric Therapeutics Limited (CHMMF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Chimeric Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Chimeric Therapeutics Limited (CHMMF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Chimeric Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Chimeric Therapeutics Limited's PE Ratio?

How is the PE Ratio calculated for Chimeric Therapeutics Limited (CHMMF)?

What is the highest PE Ratio for Chimeric Therapeutics Limited (CHMMF)?

What is the 3-year average PE Ratio for Chimeric Therapeutics Limited (CHMMF)?

What is the 5-year average PE Ratio for Chimeric Therapeutics Limited (CHMMF)?

How does the current PE Ratio for Chimeric Therapeutics Limited (CHMMF) compare to its historical average?